USPTO Reduces Fees for Trademark Applications and Renewals in 2015
Effective January 17, 2015, the USPTO has announced a number of fee reductions for 2015, including a $50 reduction in the cost to file electronic applications down from $325 to $275 per Class, and a $100 reduction in the cost to file a renewal application – to $300 from $400 per Class.
WiLAN and TRENDnet Sign License Renewal
WiLAN and TRENDnet, Inc. have signed a multi-year patent license renewal agreement. The running royalty license covers certain TRENDnet products. TRENDnet’s product portfolio includes wireless, wired, surveillance, connectivity, and peripheral device categories.
Tekmira merges with firm developing HBV cure
With the objective of creating an all-oral cure for hepatitis B infection, Tekmira Pharmaceuticals Corporation merges with OnCore Biopharma, Inc. The companies announced today that they have agreed to merge to create a new leading global HBV company focused on developing a curative regimen for hepatitis B patients by combining multiple therapeutic approaches.
Helsinn Reaches Settlement Agreement Regarding Patent Dispute on ALOXI
Helsinn Healthcare SA announces that it has entered into a settlement agreement with Sandoz Inc. to resolve their patent litigations relating to Helsinn Healthcare’s Aloxi® (palonosetron HCl injection) in the US, where it is currently distributed by Helsinn Healthcare’s marketing partner, Eisai Inc.
Cellmid granted Australian patent for midkine hair growth
Cellmid has received a key Australian patent for use of midkine to prevent and treat hair loss and to promote and enhance hair growth.
Read More
Patent Reveals the Past (and Future?) of Google Glass
A patent recently published on the USPTO’s website filed by Google in 2011 shows the idea that Google may have had for Google Glass. One of the diagrams, shows Google’s idea for the shape of the glasses, the positioning of the camera, and the location of the processor and projector of the glasses.
Cellectis announces gene-editing patent
Cellectis announces the issuance by the USPTO of US patent 8,921,332 covering chimeric endonucleases for chromosomal gene editing by homologous recombination in cells
Read More
Apple Inherits PrimeSense’s IP Relating to a 3D Scanning Engine
Apple’s inherited patent application states that “Various methods are known in the art for optical 3D mapping, i.e., generating a 3D profile of the surface of an object by processing an optical image of the object. This sort of 3D profile is also referred to as a 3D map, depth map or depth image, and 3D mapping is also referred to as depth mapping.
Samsung Electronics inks licensing agreement with University of Michigan spinoff
A University of Michigan-developed energy storage and controls company announced Thursday that it has signed a technology licensing agreement with Korean tech giant Samsung Electronics.
Alnylam and Isis Form New Agreement
Isis Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc., leaders in RNA-targeted therapeutics, announced today they have formed a new agreement, extending their existing strategic partnership – formed originally in 2004 – to lead the development and commercialization of RNA therapeutics.
Pendrell Enters into Memory Technologies Agreement with SK hynix
Pendrell Corporation today announced that it has entered into a patent license agreement with SK hynix Inc. covering embedded Multimedia Card (eMMC) memory technologies. This license agreement enables SK hynix to use both the standards essential and implementation technologies invented by Pendrell’s team.
MedGenome Licenses Natera NIPT Technology for India
Clinical genomic testing firm MedGenome and Natera have reached an exclusive agreement to provide Natera’s Panorama non-invasive prenatal test in India.
Melinta Therapeutics and Eurofarma Laboratorios Enter into Commercialization and Distribution Agreements
Melinta Therapeutics and Eurofarma Laboratórios, one of the largest pharmaceutical companies in Brazil, announced that the companies have entered into commercialization and distribution agreements for delafloxacin, an investigational fluoroquinolone.
Incyte and Agenus Announce Global Alliance to Develop Novel Immuno-Oncology Antibodies
Incyte Corporation and Agenus Inc. today announced a global license, development and commercialization agreement focused on novel immuno-therapeutics using Agenus’ proprietary Retrocyte Display™ antibody discovery platform
Solacom granted 3 U.S. Patents for public safety technology
Solacom technologies, a leading ng9-1-1 solutions developer, announced that it has been issued three new patents by the united states patent and trademark office. The patents reflect Solacoms ongoing investment in new technologies that have application in Public Safety and beyond.
Read More
Altos Therapeutics announces issuance of Mexican patent covering dopamine D2/D3 drug candidates
Altos Therapeutics, LLC announced today that the Mexican Institute of Industrial Property has issued Patent Number 323020 titled, “D2 Antagonists, Methods of Synthesis and Methods of Use”.
California Court Dismisses Class Action lawsuit over MacBook Logic Boards but other Similar Cases Still Remain
In a Class action filed on behalf of Uriel Marcus and Benedict Verceles covering ten areas of law, yesterday U.S. District Judge William Alsup in San Francisco said the plaintiffs had failed to show that Apple made affirmative misrepresentations and the case dismissed.
